Myocardial steatosis as a possible mechanistic link between diastolic dysfunction and coronary microvascular

Janet Wei1, Michael D Nelson2, Edward W Szczepaniak2

  • 1Barbra Streisand Women's Heart Center, Cedars-Sinai Heart Institute, Los Angeles, California; janet.wei@cshs.org.

Insights

Women with coronary microvascular dysfunction (CMD) experience heart failure with preserved ejection fraction (HFpEF). Myocardial steatosis, or heart fat, was more prevalent in these women, contributing to diastolic dysfunction.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Metabolic Heart Disease

Background:

  • Coronary microvascular dysfunction (CMD) without obstructive coronary artery disease (CAD) is linked to increased heart failure with preserved ejection fraction (HFpEF) in women.
  • The underlying mechanisms of HFpEF in this population remain unclear.
  • Myocardial steatosis (ectopic fat in the heart muscle) is associated with diastolic dysfunction in other metabolic conditions.

Purpose of the Study:

  • To investigate the prevalence of myocardial steatosis and diastolic dysfunction in women with CMD and subclinical HFpEF.
  • To explore the relationship between myocardial fat content and diastolic function in this specific patient group.

Main Methods:

  • Study included 13 women: 8 controls and 5 with CMD and subclinical HFpEF (elevated left ventricular end-diastolic pressure).
  • Myocardial triglyceride content was measured using proton magnetic resonance spectroscopy.
  • Diastolic function was assessed via magnetic resonance tissue tagging.

Main Results:

  • Women with CMD exhibited significantly higher myocardial triglyceride content compared to controls (0.83% ± 0.12% vs. 0.43% ± 0.06%, P = 0.025).
  • Diastolic circumferential strain rate was lower in women with CMD (168 ± 12%/s vs. 217 ± 15%/s, P = 0.012).
  • Myocardial triglyceride content showed a significant inverse correlation with diastolic circumferential strain rate (r = -0.779, P = 0.002).

Conclusions:

  • This proof-of-concept study suggests myocardial steatosis may be a key factor in diastolic dysfunction among women with CMD and no obstructive CAD.
  • Further longitudinal research is needed to confirm these findings and evaluate targeted treatments for myocardial steatosis.
  • Understanding the role of myocardial fat could lead to novel therapeutic strategies for HFpEF in women with CMD.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
960
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
757
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.3K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
574